Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis July 30, 2019 - NASDAQ Companies 0 » View More News for July 30, 2019